Smith & Nephew plc (NYSE:SNN) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Smith & Nephew plc (NYSE:SNN) have earned an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company.

Several equities research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft started coverage on Smith & Nephew in a research note on Wednesday, July 24th. They set a “buy” rating for the company. StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Monday, August 5th. Finally, UBS Group upgraded shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research report on Wednesday, June 5th.

Smith & Nephew Price Performance

Smith & Nephew stock opened at $30.88 on Monday. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew has a one year low of $21.52 and a one year high of $31.13. The business has a fifty day moving average price of $27.97 and a 200-day moving average price of $26.61.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of SNN. International Assets Investment Management LLC purchased a new stake in shares of Smith & Nephew in the 4th quarter worth about $716,000. abrdn plc bought a new stake in Smith & Nephew during the 4th quarter valued at approximately $4,957,000. Signaturefd LLC boosted its position in Smith & Nephew by 51.6% during the 4th quarter. Signaturefd LLC now owns 8,070 shares of the medical equipment provider’s stock valued at $220,000 after acquiring an additional 2,748 shares in the last quarter. CWM LLC grew its holdings in shares of Smith & Nephew by 68.6% during the 4th quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 388 shares during the period. Finally, GAMMA Investing LLC bought a new position in shares of Smith & Nephew in the 4th quarter worth approximately $53,000. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.